General Information

Age Group

Adults

Status

Recruiting

Protocol Number

n/a

Background Information

The primary objective is to determine if implantation of a permanent CRT pacing device can improve electromechanical function, HF symptoms and natriuretic peptide levels among patients with HF, LVEF > 35% and LBBB.

Offered At

Inova Arrhythmia - Fairfax
8081 Innovation Park Dr., #602
Inova Specialty Center
Fairfax, VA 22031
Principal Investigator

Brett Atwater, MD

Eligibility Information

  • Strict LBBB defined as QRS duration ≥ 130 ms in women and ≥ 140 ms in men, NYHA II / III or ambulatory IV, stable guideline directed HF medical regimen.

Ineligibility Information

  • Anticipated addition or titration of HF medical therapies
  • Unrevascularized coronary artery disease, unstable angina